142 related articles for article (PubMed ID: 26034081)
21. New analogs of SYA013 as sigma-2 ligands with anticancer activity.
Asong G; Zhu XY; Bricker B; Andey T; Amissah F; Lamango N; Ablordeppey SY
Bioorg Med Chem; 2019 Jun; 27(12):2629-2636. PubMed ID: 30987780
[TBL] [Abstract][Full Text] [Related]
22. The sigma-1 receptor antagonist PB212 reduces the Ca²⁺-release through the inositol (1, 4, 5)-trisphosphate receptor in SK-N-SH cells.
Gasparre G; Abate C; Berardi F; Cassano G
Eur J Pharmacol; 2012 Jun; 684(1-3):59-63. PubMed ID: 22465185
[TBL] [Abstract][Full Text] [Related]
23. Sigma-2 receptor agonists as possible antitumor agents in resistant tumors: hints for collateral sensitivity.
Niso M; Abate C; Contino M; Ferorelli S; Azzariti A; Perrone R; Colabufo NA; Berardi F
ChemMedChem; 2013 Dec; 8(12):2026-35. PubMed ID: 24106081
[TBL] [Abstract][Full Text] [Related]
24. Exploring the importance of piperazine N-atoms for sigma(2) receptor affinity and activity in a series of analogs of 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28).
Berardi F; Abate C; Ferorelli S; Uricchio V; Colabufo NA; Niso M; Perrone R
J Med Chem; 2009 Dec; 52(23):7817-28. PubMed ID: 19842660
[TBL] [Abstract][Full Text] [Related]
25. 4-(tetralin-1-yl)- and 4-(naphthalen-1-yl)alkyl derivatives of 1-cyclohexylpiperazine as sigma receptor ligands with agonist sigma2 activity.
Berardi F; Ferorelli S; Abate C; Colabufo NA; Contino M; Perrone R; Tortorella V
J Med Chem; 2004 Apr; 47(9):2308-17. PubMed ID: 15084129
[TBL] [Abstract][Full Text] [Related]
26. 2-Aminopyridine derivatives as potential σ(2) receptor antagonists.
Abate C; Ferorelli S; Niso M; Lovicario C; Infantino V; Convertini P; Perrone R; Berardi F
ChemMedChem; 2012 Oct; 7(10):1847-57. PubMed ID: 22890883
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and pharmacological evaluation of benzannulated derivatives as potent and selective sigma-1 protein ligands.
Donnier-Maréchal M; Carato P; Le Broc D; Furman C; Melnyk P
Eur J Med Chem; 2015 Mar; 92():575-82. PubMed ID: 25602932
[TBL] [Abstract][Full Text] [Related]
28. The sigma receptor ligand (+)-pentazocine prevents apoptotic retinal ganglion cell death induced in vitro by homocysteine and glutamate.
Martin PM; Ola MS; Agarwal N; Ganapathy V; Smith SB
Brain Res Mol Brain Res; 2004 Apr; 123(1-2):66-75. PubMed ID: 15046867
[TBL] [Abstract][Full Text] [Related]
29. Identification of a potent and selective σ₁ receptor agonist potentiating NGF-induced neurite outgrowth in PC12 cells.
Rossi D; Pedrali A; Urbano M; Gaggeri R; Serra M; Fernández L; Fernández M; Caballero J; Ronsisvalle S; Prezzavento O; Schepmann D; Wuensch B; Peviani M; Curti D; Azzolina O; Collina S
Bioorg Med Chem; 2011 Nov; 19(21):6210-24. PubMed ID: 21967807
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and in vitro Evaluation of Novel Indole-Based Sigma Receptors Ligands.
Yarim M; Koksal M; Schepmann D; Wünsch B
Chem Biol Drug Des; 2011 Nov; 78(5):869-75. PubMed ID: 21848665
[TBL] [Abstract][Full Text] [Related]
31. Propofol acts at the sigma-1 receptor and inhibits pentazocine-induced c-Fos expression in the mouse posterior cingulate and retrosplenial cortices.
Yamada M; Nakao S; Sakamoto S; Takamori Y; Tamura Y; Mochizuki-Oda N; Kataoka Y; Yamada H; Shingu K
Acta Anaesthesiol Scand; 2006 Aug; 50(7):875-81. PubMed ID: 16879472
[TBL] [Abstract][Full Text] [Related]
32. Sigma-1 receptor stimulation protects retinal ganglion cells from ischemia-like insult through the activation of extracellular-signal-regulated kinases 1/2.
Mueller BH; Park Y; Ma HY; Dibas A; Ellis DZ; Clark AF; Yorio T
Exp Eye Res; 2014 Nov; 128():156-69. PubMed ID: 25305575
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and potential cytotoxic activity of some new benzoxazoles, imidazoles, benzimidazoles and tetrazoles.
Arulmurugan S; Kavitha HP
Acta Pharm; 2013 Jun; 63(2):253-64. PubMed ID: 23846147
[TBL] [Abstract][Full Text] [Related]
34. Dimemorfan protects rats against ischemic stroke through activation of sigma-1 receptor-mediated mechanisms by decreasing glutamate accumulation.
Shen YC; Wang YH; Chou YC; Liou KT; Yen JC; Wang WY; Liao JF
J Neurochem; 2008 Jan; 104(2):558-72. PubMed ID: 18173806
[TBL] [Abstract][Full Text] [Related]
35. Cyclohexylpiperazine derivative PB28, a sigma2 agonist and sigma1 antagonist receptor, inhibits cell growth, modulates P-glycoprotein, and synergizes with anthracyclines in breast cancer.
Azzariti A; Colabufo NA; Berardi F; Porcelli L; Niso M; Simone GM; Perrone R; Paradiso A
Mol Cancer Ther; 2006 Jul; 5(7):1807-16. PubMed ID: 16891467
[TBL] [Abstract][Full Text] [Related]
36. sigma(2) Receptors regulate changes in sphingolipid levels in breast tumor cells.
Crawford KW; Coop A; Bowen WD
Eur J Pharmacol; 2002 May; 443(1-3):207-9. PubMed ID: 12044812
[TBL] [Abstract][Full Text] [Related]
37. Novel highly potent and selective sigma 1 receptor antagonists related to spipethiane.
Piergentili A; Amantini C; Del Bello F; Giannella M; Mattioli L; Palmery M; Perfumi M; Pigini M; Santoni G; Tucci P; Zotti M; Quaglia W
J Med Chem; 2010 Feb; 53(3):1261-9. PubMed ID: 20067271
[TBL] [Abstract][Full Text] [Related]
38. Cytotoxicity of sigma-receptor ligands is associated with major changes of cellular metabolism and complete occupancy of the sigma-2 subpopulation.
Rybczynska AA; Dierckx RA; Ishiwata K; Elsinga PH; van Waarde A
J Nucl Med; 2008 Dec; 49(12):2049-56. PubMed ID: 18997057
[TBL] [Abstract][Full Text] [Related]
39. Simple ammonium salts acting on sigma-1 receptors yield potential treatments for cancer and depression.
Brimson JM; Akula KK; Abbas H; Ferry DR; Kulkarni SK; Russell ST; Tisdale MJ; Tencomnao T; Safrany ST
Sci Rep; 2020 Jun; 10(1):9251. PubMed ID: 32514120
[TBL] [Abstract][Full Text] [Related]
40. Irreversible blockade of sigma-1 receptors by haloperidol and its metabolites in guinea pig brain and SH-SY5Y human neuroblastoma cells.
Cobos EJ; del Pozo E; Baeyens JM
J Neurochem; 2007 Aug; 102(3):812-25. PubMed ID: 17419803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
